• Ceftazidime in Translational Research: Resistance and Strate

  2026-05-06

  This thought-leadership article examines Ceftazidime’s mechanistic and translational role in combating Gram-negative bacterial resistance. Blending recent multidrug resistance data with actionable protocol guidance, it empowers researchers to design robust studies and anticipate future clinical challenges. The discussion uniquely integrates transmission dynamics, laboratory workflow optimization, and APExBIO’s advanced product intelligence.

• Maraviroc (UK-427857): Strategic CCR5 Antagonism in Neuroinf

  2026-05-05

  Discover how Maraviroc (UK-427857) enables advanced studies in HIV-1 entry inhibition and neuroinflammation modulation. This article explores nuanced assay design, cutting-edge applications, and insights from the latest inflammation research.

• Applied Insights: (-)-Blebbistatin in Non-Muscle Myosin II I

  2026-05-05

  (-)-Blebbistatin unlocks precise, reversible control of cytoskeletal mechanics for advanced study of cell adhesion, migration, and mechanotransduction. This article delivers workflow-anchored guidance for optimizing actin-myosin interaction inhibition, troubleshooting, and leveraging recent breakthroughs in force-mode dependent gene regulation.

• Hypoxia-Induced S100A10 Drives Glioblastoma Proliferation an

  2026-05-04

  This study identifies hypoxia-induced S100A10 upregulation as a pivotal driver of glioblastoma (GBM) malignancy and chemoresistance by activating the PI3K-AKT signaling pathway. The findings reveal S100A10’s role in promoting proliferation, glycolysis, and survival in GBM, highlighting its potential as a prognostic biomarker and therapeutic target.

• PEGylated Iron Oxide Nanoparticles: Decoding Hepatic Uptake

  2026-05-04

  This ACS Nano study investigates how iron oxide nanoparticles with varying sizes and PEG chain lengths interact with distinct liver cell types, challenging widely held assumptions about hepatic clearance. The findings provide actionable insight for designing nanomedicines with optimized biodistribution and reduced off-target effects.

• Bazedoxifene: Selective Estrogen Receptor Modulator in Resea

  2026-05-03

  Bazedoxifene, a third-generation SERM, uniquely addresses postmenopausal osteoporosis and estrogen receptor pathway studies with high selectivity and reliable performance. This guide details optimal workflows, troubleshooting strategies, and comparative insights for maximizing research outcomes using Bazedoxifene from APExBIO.

• Reliable Assays with EZ Cap™ Firefly Luciferase mRNA (R1018)

  2026-05-02

  This article demonstrates how EZ Cap™ Firefly Luciferase mRNA (SKU R1018) addresses core challenges in cell-based assays through enhanced cap structure and poly(A) tail optimization. Detailed scenario-based Q&As guide researchers in protocol design, data interpretation, and product selection, ensuring reproducibility and robust luminescent reporting for mRNA delivery, gene regulation, and in vivo imaging.

• α7nAChR-Driven Pyroptosis in HIV-1 gp120-Induced BBB Breakdo

  2026-05-02

  This study uncovers a previously unrecognized mechanism by which HIV-1 gp120 induces blood–brain barrier breakdown: brain endothelial pyroptosis driven by the α7 nicotinic acetylcholine receptor (α7nAChR) via the ROS/NF-κB/NLRP3 inflammasome axis. The findings not only redefine the pathogenic role of α7nAChR in HIV-associated neurocognitive disorder but also highlight drug repurposing opportunities using memantine and metformin to preserve BBB integrity.

• Applied Workflows with Recombinant Human EGF: Protocols & In

  2026-05-01

  Harness the power of recombinant human EGF for high-efficiency cell culture, stemness assays, and mucosal protection models. This guide details evidence-backed protocols, cutting-edge workflow enhancements, and troubleshooting insights to maximize reproducibility and biological impact.

• PSMD13 as a Prognostic and Immune Modulator in Liver Cancer

  2026-04-30

  This study identifies PSMD13 as a prognostic biomarker with key roles in tumor progression and immune microenvironment modulation in hepatocellular carcinoma. Using integrated bioinformatics and immunohistochemistry, the authors link PSMD13 expression to immune infiltration, particularly M2 macrophages, and patient outcomes, offering new insights for immunotherapy strategies.

• PP 2 (AG 1879): Src Kinase Inhibition in Cancer and Vascular

  2026-04-30

  PP 2 (AG 1879) enables precision inhibition of Src-family kinases, empowering researchers to dissect cancer signaling and immune cell activation with nanomolar potency. This guide delivers stepwise protocols, advanced applications, and troubleshooting strategies, featuring insights from recent vascular research to maximize experimental value.

• PP2A-Regulated Autophagy Drives Drug Resistance in C. albica

  2026-04-29

  This study uncovers how protein phosphatase 2A (PP2A) modulates autophagy through ATG protein phosphorylation, directly enhancing biofilm formation and antifungal drug resistance in Candida albicans. The findings provide mechanistic insight into persistent resistance and suggest new targets for antifungal intervention.

• Molnupiravir Inhibits Bourbon Virus: Mouse Model Efficacy In

  2026-04-29

  This study demonstrates that molnupiravir, an oral broad-spectrum antiviral, can significantly inhibit Bourbon virus (BRBV) replication and pathology in a lethal mouse model. The findings highlight molnupiravir’s therapeutic potential against emerging tick-borne orthomyxoviruses, providing a rigorous basis for further translational research and comparison with established RNA virus antivirals.

• circ_0001944 Modulates FXR/TLR4 and Ferroptosis in NiONP-Ind

  2026-04-28

  This study uncovers a novel regulatory mechanism whereby hsa_circ_0001944 controls the FXR/TLR4 pathway and ferroptosis to mitigate nickel oxide nanoparticle (NiONP)-induced collagen formation in hepatic stellate cells. The work demonstrates that upregulation of FXR by hsa_circ_0001944 attenuates fibrogenic processes, offering new perspectives for research into liver fibrosis and the intersection of nuclear receptor signaling, non-coding RNAs, and cell death mechanisms.

• Go 6983 (pan-PKC Inhibitor): Applied Protocols in PKC Signal

  2026-04-28

  Go 6983 enables high-precision modulation of PKC-dependent pathways, empowering researchers to dissect cancer, EMT, and neurobehavioral circuits with reproducible workflows. This article translates new mechanistic findings into actionable bench protocols and troubleshooting strategies for robust PKC signaling pathway research.

449 records 19/30 page Previous Next First page 上5页 1617181920 下5页 Last page